Form 4 for AGEN AGENUS INC
Accepted 2024-06-18 00:00:00 ET · period of report 2024-06-11 · accession 0000950170-24-074741 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-06-18 | 2024-06-14 | AGEN | ARMEN GARO H | See Remarks, Dir | A - Grant | $15.46 | +1,055 | 74.6K | +1% | +$16.3K |
| DM | 2024-06-18 | 2024-06-11 | AGEN | ARMEN GARO H | See Remarks, Dir | A - Grant | $0.00 | +173.7K | 65.7K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-06-14 | A | A | 1,055 | $15.46 | 74,642 | D | — | — | (F1) At his request and with the approval of the Agenus Inc. Compensation Committee, Garo H. Armen's salary is being paid in stock, in lieu of cash. The amount reported herein represents the net amount of Dr. Armen's salary for the pay period ending June 14, 2024. Such shares are issued in accordance with the Amended and Restated Agenus Inc. 2019 Equity Incentive are fully vested on the date of issuance. (F2) $15.46 is the closing price of our Common Stock on June 14, 2024, the payroll date for the pay period ending June 14, 2024. |
| 2 | Derivative | Stock Option | 2024-06-11 | A | A | 108,000 | $0.00 | 108,000 | D | $11.90 · — to 2034-01-11 | 108,000 Common Stock | (F6) Options were granted on January 17, 2024 subject to shareholder approval, which was obtained at the Company's annual shareholder meeting on June 11, 2024. Option awarded in accordance with the Agenus Inc. 2019 Amended and Restated Equity Incentive Plan, and vests over three years with one-third of the award vesting on January 16, 2025 and the balance vesting in equal quarterly installments thereafter. The Stock Options were granted prior to the 1 for 20 reverse stock split, representing 2,160,000 Stock Options with an exercise price of $0.59. |
| 3 | Derivative | Stock Option | 2024-06-11 | A | A | 65,651 | $0.00 | 65,651 | D | $11.90 · — to 2034-01-17 | 65,651 Common Stock | (F5) Options were granted on January 17, 2024 subject to shareholder approval, which was obtained at the Company's annual shareholder meeting on June 11, 2024. Option awarded in accordance with the Agenus Inc. 2019 Amended and Restated Equity Incentive Plan. These options vest as to 50% of the underlying shares on June 27, 2024 and 50% of the underlying shares on September 27, 2024. The Stock Options were granted prior to the 1 for 20 reverse stock split, representing 1,313,020 Stock Options with an exercise price of $0.59. |